Charles D. Goodwin II - Jan 19, 2022 Form 4 Insider Report for Apyx Medical Corp (APYX)

Role
Chief Executive Officer, Director
Signature
s/ Charles D. Goodwin, II
Stock symbol
APYX
Transactions as of
Jan 19, 2022
Transactions value $
$0
Form type
4
Date filed
1/31/2022, 06:11 PM
Next filing
Aug 31, 2022

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction APYX Stock Option (Option to Buy) Award $0 +243K $0.00 243K Jan 19, 2022 Common Stock 243K $10.96 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Reporting person was granted a stock option which shall vest ratably over a thirty six (36) month period and shall become fully vested and fully exercisable on the third anniversary of the date of grant.